In astrocytoma, irradiation and chemotherapy had no diverging effects on cognitive functions when comparing the extent of cognitive change in RT+  and RT- patients and ChT+ and ChT- patients, respectively (all ps ≥ 0.150, not shown). The gene discussed is SLC5A7; the disease is astrocytoma (excluding glioblastoma).